The Scientist

» biotech, developmental biology and culture

Most Recent

image: Bacteriophages to the Rescue

Bacteriophages to the Rescue

By | July 17, 2017

Phage therapy is but one example of using biological entities to reduce our reliance on antibiotics and other failing chemical solutions.

6 Comments

image: Book Excerpt from <em>Natural Defense</em>

Book Excerpt from Natural Defense

By | July 17, 2017

In Chapter 3, “The Enemy of Our Enemy Is Our Friend: Infecting the Infection,” author Emily Monosson makes the case for bacteriophage therapy in the treatment of infectious disease.

0 Comments

Research shows that human immunity develops much earlier than previously thought, but functions differently in adults.

0 Comments

image: Art’s Diagnosticians

Art’s Diagnosticians

By | June 12, 2017

Physicians peer into the subjects of artistic masterpieces, and find new perspective on their own approach to diagnosing maladies.

0 Comments

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

image: CAR T-Cell Trials Boast Promising Results

CAR T-Cell Trials Boast Promising Results

By | June 6, 2017

The results of two small clinical trials show that the immunotherapy is effective for multiple myeloma patients, at least in the near term.

0 Comments

image: Book Excerpt from <em>Behave</em>

Book Excerpt from Behave

By | June 1, 2017

In the book’s introduction, author and neuroendocrinologist Robert Sapolsky explains his fascination with the biology of violence and other dark parts of human behavior.

0 Comments

The human brain’s insular cortex is adept at registering distaste for everything from rotten fruit to unfamiliar cultures.

1 Comment

image: Learning from Iceland’s Model for Genetic Research

Learning from Iceland’s Model for Genetic Research

By | June 1, 2017

The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.

1 Comment

image: Former Head of Genzyme Dies

Former Head of Genzyme Dies

By | May 15, 2017

Henri Termeer helped usher the biotech company into an industry behemoth.

0 Comments

Popular Now

  1. So You’ve Been Mistaken as a White Nationalist
  2. Opinion: We Need a Replacement for Beall’s List
  3. Trump Releases Science Spending Priorities for FY2019
  4. Seeding the Gut Microbiome Prevents Sepsis in Infants
AAAS